Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Sandra L. Pfister PhD
Professor
Department of Pharmacology and Toxicology

OFFICE ADDRESS:
Basic Science Building
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
08/1974 - 05/1978 B.S., St. Mary's University, San Antonio, TX
08/1978 - 05/1984 Ph.D., University of Texas Health Science Center (UTHSC), San Antonio, TX

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
08/1978 - 05/1984 Teaching Assistant, Pharmacology & Toxiocology, UTHSC, San Antonio, TX
06/1984 - 12/1984 Postdoctoral Fellow, Pharmacology & Toxiocology, UTHSC, San Antonio, TX
01/1985 - 09/1988 Postdoctoral Fellow, Pharmacology, UT Southwestern Medical Center, Dallas, TX

FACULTY APPOINTMENTS:
01/1982 - 05/1982 Adjunct Faculty, St. Mary's University, San Antonio, TX
09/1988 - 05/1992 Instructor, Pharmacology, UT Southwestern Medical Center, Dallas, TX
06/1992 - 07/1998 Assistant Professor, Pharmacology & Toxiocology, Medical College of Wisconsin, Milwaukee, WI
08/1998 - 06/2018 Associate Professor, Pharmacology & Toxiocology, Medical College of Wisconsin, Milwaukee, WI
07/2018 - Present Professor, Pharmacology & Toxicology, Medical College of Wisconsin

ADMINISTRATIVE APPOINTMENTS:
07/2017 - Present Member, Faculty Pillar, Kern Institute for Transformation of Medical Education, Medical College of Wisconsin

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
01/2012 - Present M2 Cardiovascular Unit Director, Medical College of Wisconsin
10/2017 - Present Course Director, Principles of Drug Action, Medical College of Wisconsin

AWARDS AND HONORS:
1976 Delta Epsilon Sigma Honor Society
1996 Finalist for the 1996 Council for High Blood Pressure Research Harry Goldblatt Award in Cardiovascular Research
1996 Elected Fellow of the Council for High Blood Pressure Research
1997 Recipient of the 1997 Council for High Blood Pressure Research Harry Goldblatt Award in Cardiovascular Research
2017 Society for Teaching Scholars, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1993 - Present American Heart Association Council on Basic Science Member (Member)
1995 - Present American Society for Pharmacology & Experimental Therapeutics (Member)
1996 - Present Fellow of the Council for High Blood Pressure Research (American Heart Association)
2012 - Present Organization for the Study of Sex Differences (Member)
2016 - Present American Association of University Women (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
2006 - Present Journal of Pharmacology & Experimental Therapeutics
Journal Review
Cardiovascular Drugs and Therapy
Journal of Lipid Research
Atherosclerosis
Biochimica et Biophysica Acta - Lipids and Lipid Metabolism
General Pharmacology
Journal of Cardiovascular Pharmacology
Journal of Pharmacology and Experimental Therapeutics
Physiological Genomics
American Journal of Physiology
Hypertension
Placenta
Prostaglandins and Other Lipid Mediators
British Journal of Pharmacology
European Journal of Pharmacology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
03/1998 - 03/1999 Member, Peer Review Committee, Northland Affiliate, AHA
02/2012 - 06/2015 Member, Search Committee for Regional Campus Deans, MCW
07/2013 - 2016 Member, Women's Faculty Council, MCW
07/2014 - 06/2016 Chair, Faculty Credentials Committee, MCW
05/2016 - Present Member, Teaching, Vision and Brand Strategy Experience Team, MCW
07/2016 - 06/2017 Vice-Chair, Academic Standing and Professionalism Committee, MCW
08/2016 - 05/2017 Member, MCW Leadership Academy, MCW/UWM
09/2016 - 06/2017 Chair, Council for Women's Advocacy, MCW
01/2017 - 04/2017 Member, Pharmacology Faculty Search, MCW School of Pharmacy
07/2017 - 06/2018 Chair, Council for Women's Advocacy, MCW
10/2018 - Present Chair, Task Force on Grading Change to U/S in Preclinical Years, MCW

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
06/2002 Ad Hoc Reviewer, VA Grant Review
12/2002 Ad Hoc Reviewer, Health Research Board, Ireland
10/2006 Ad Hoc Reviewer, Kentucky Science and Engineering Foundation
04/2009 - Present Reviewer, Vascular Biology Section, AHA
06/2009 Ad Hoc Reviewer, Challenge Grants, NIH, RIBT Study Section
02/2010 - Present Ad Hoc Reviewer, NIH, RIBT Study Section
04/2012 Innovative Research Grant Review, AHA
2015 - Present Reviewer, Lung Biology Peer Review, AHA

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Estrogen and 15-HETE in Modulation of Vascular Tone
Source:
AHA
Role:
PI
PI:
Sandra Pfister
Dates:
07/2016 - 06/2019
Direct Funds:
$130,000 (no-cost extension)
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Cardiovascular Research Center, Endothelial Cell Biology Symposium, MCW, 01/1993
Department of Physiology, MCW, 11/1994
Department of Anesthesiology, Veterans Affairs Medical Center, Milwaukee, WI, 04/1995
Women's Health Research Program, Department of Ob-Gyn, MCW, 11/16/2011
Science Needs More Females in the Laboratory (and not just humans), Kaleidoscope-A Research Forum with a Diversity Lens, Medical College of Wisconsin, 03/30/2016
Vascular Thromboxane Receptors, Atherosclerosis & Thrombosis Signature Program Meeting, MCW, 11/21/2016
Estrogen, 15-Lipoxygensae, Pulmonary Vascular Function, Atherosclerosis & Thrombosis Signature Program Meeting, MCW, 02/14/2017
Estrogen Paradox Understanding Female Predominance in Pulmonary Hypertension, ATVB Signature Program Meeting, MCW, 02/19/2018
 
National
Department of Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 05/1993
Winter Eicosanoid Conference 2000, Baltimore, MD, 03/2000
EDHF: chemical nature and sites of action, Experimental Biology 2001; The American Physiological Society Symposia, Orlando, FL, 04/2001
University of North Texas State Health Science Center, Department of Integrative Physiology, Fort Worth, TX, 03/2003
Department of Pediatrics, Wake Forest University School of Medicine, 03/2005
Department of Pharmacology, Rush University Medical Center, Chicago, IL, 06/2010
Association of Moral Education, St. Louis, Missouri, 11/03/2017
 
International
Second Workshop on Endothelium-Derived Hyperpolarizing Factor, Abbaye des Vaux de Cernay, France, 06/1998
Third Workshop on Endothelium-Derived Hyperpolarizing Factor, Abbaye des Vaux de Cernay, France, 06/2000
 

COMMITTEE SERVICE:
Medical College
1994 - 2002 Member, Animal Care Committee
1996 - 1998 Member, Graduate Student Welfare Committee
1997 - 2000 Member, Academic Standing Committee
1999 - 2001 Member, Graduate Student Curriculum Committee
2001 - 2003 Member, Graduate Student Awards Committee
2006 - Present Alternate Member, Institutional Animal Care and Use Committee
2006 - 2017 Member, Graduate School Interdisciplinary Program Recruiting Committee
2007 - 2010 Member, Faculty Benefits Committee
2011 - 2016 Member, Scholarly Activities Work Group
07/2012 - Present Member, Academic Standing and Professionalism Committee
2012 - Present Member, Pharmacology Content Expert Heme-Lymph
02/2013 - 06/2015 Member, Search Committee for Campus Dean, Community Medical Education Program
07/2013 - 06/2016 Member, Council for Women's Advocacy, Medical College of Wisconsin
07/2013 - 06/2016 Member, Faculty Credentials Committee
10/2014 - Present Member, Curriculum and Evaluation Committee
09/2016 - Present Member, Keywords Work Group, MCW
04/2017 - Present Member, Student-Directed Learning Work Group, MCW
06/2018 - Present Member, Task Force on #MeToo, MCW
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
1989 - 1991 Pharmacology in the Physician's Assistants Program, Antihypertensive Drugs
1989 - 1991 Pharmacology in the Physician's Assistants Program, Diuretics
1995 - 1998 Mini-Medical School
2019 - Present Kinetic3 Teaching Academy
 
Medical Student Education
1993 - Present Principles of Drug Action formally Medical Pharmacology, Introdution to the Pharmacology of Inflammation
1993 - Present Principles of Drug Action formally Medical Pharmacology, Prostaglandins
1993 - Present Principles of Drug Action formally Medical Pharmacology, Thombolytics and Anticoagulants
1993 - 2012 Medical Pharmacology, Antihyperlipidemic Drugs
1993 - Present Principles of Drug Action formally Medical Pharmacology, Nonsteroidal Antiinflammatory Drugs
1993 - Present Principles of Drug Action formally Medical Pharmacology, Histamine
11/2010 TBL sessions for M1 Integrated Pilot Curriculum Treatment of Back Pain
01/2011 TBL sessions for M1 Integrated Pilot Curriculum Pharmacological Treatment of Acute Myocardial Infarction
02/2011 TBL sessions for M1 Integrated Pilot Curriculum Treatment of Asthma
01/2012 Treatment of Coagulation Disorders in M2 Pilot Curriculum
04/2012 Treatment of Gout; Symptoms Module, M2 Pilot Curriculum
2013 - Present M2 Symptoms Unit Joint Pain
2013 - Present M2 Cardiovascular Unit Treatment of Acute Coronary Syndrome/Thrombolytics
2013 - Present M2 Musculoskeletal Unit Pharmacology of Gout, RA and OA
2013 - Present M2 Cardiovascular Unit Pharmacology of Antilipidemics
2014 - Present M2 Renal-Respiratory Unit Pharmacology of Asthma
2014 - Present M2 Cardiovascular Unit Women and CV Disease
2015 - Present M2 Symptoms Unit Dyspnea
2015 - Present M2 Symptoms Unit Wheezing
2016 - Present Upper GI Pharmacology in M2 GI Unit
2019 - Present Pediatric Integrating Cases for M4 Students
 
Resident and Fellow Education
2014 - Present New Oral Anticoagulants
 
Graduate Student Education
1994 - Present Graduate Student Pharmacology Lectures, Phospholipases
1994 - Present Graduate Student Pharmacology Lectures, Signaling by Phospholipases and Cyclooxygenase-1 and -2
1994 - Present Graduate Student Pharmacology Lectures, Eicosanoids as Second Messengers
1994 - Present Graduate Student Pharmacology Lectures, Immunoassays
1994 - Present Graduate Student Pharmacology Lectures, Statins as Cholesterol-Lowering Drugs in Cardiovascular Disease
1998 Course Director for Principles of Drug Action I- Receptors
2004 - 2006 Biochemistry of the Cell/ Mechanisms of cellular signaling, Steroid metabolism
2004 - 2006 Biochemistry of the Cell/ Mechanisms of cellular signaling, Gene regulation of cholesterol metabolism
2006 - Present Biochemistry of the Cell/ Mechanisms of cellular signaling, Atherosclerosis; role of cholesterol and inflammation,
 

EXTRAMURAL TEACHING:
Community/Lay Public
1996 - 1999 Marquette University, Pharmacology in the Marquette University Graduate Nursing Program, Antihyperlipidemic Drugs
1996 - 1999 Marquette University, Pharmacology in the Marquette University Graduate Nursing Program, Antihypertensive Drugs
1996 - 1999 Marquette University, Pharmacology in the Marquette University Graduate Nursing Program, Diuretics
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Faculty
06/2014 Exploring Effective Teaching Techniques in Discovery Curriculum, WFC-FCDC sponsored
03/30/2016 Presentation on Women's Health-Kaleidoscope
08/2016 - 08/2017 Capstone Project "Development of a Sex and Gender Medicine Curriculum for MCW Students" MCW Leadership Academy
06/2017 Designing Student-Centered Learning Experiences as part of Summer Institute at Olin College Collaboratory
 
 
 
 

COMMUNITY SERVICE ACTIVITIES:
09/1997 - Present Teach catechism-ESCYM, Milwaukee, WI
04/09/2016 - Present Engaging Girls in Science; 2016 Prep-Pro Workshop (Preparing to be a Professional).
2016 - Present Member, Women in Science
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Pfister, S.L., Keeton, T.K.: Yohimbine induces sympathetically-mediated renin release in the conscious rat. Eur. J. Pharmacol. 97:247-255, 1984.
2. Pfister, S.L., Keeton, T.K.: The mechanism of yohimbine-induced renin release in the conscious rat. Naunyn-Schmeideberg's Arch. Pharmcol. 337:35-46, 1988.
3. Hubbard, J.W., Pfister, S.L., Biediger, A.M., Herzig, T.C, Keeton, T.K.: The pharmacokinetic properties of yohimbine in the conscious rat. Naunyn-Schmeid. Arch. Pharmacol. 337:583-587, 1988.
4. Pfister, S.L., Keeton, T.K.: Angiotensin II contributes to blood pressure maintenance in conscious rats treated with yohimbine. Eur. J. Pharmacol. 149:377-380, 1988.
5. Pfister, S.L., Schmitz, J.M., Willerson, J.T.,Campbell, W.B.: Characterization of arachidonic acid metabolism in Watanabe Heritable Hyperlipidemic (WHHL) and New Zealand White (NZW) rabbit aortas. Prostaglandins 36:515-532, 1988.
6. Wines, P.A., Schmitz, J.M., Pfister, S.L., Clubb, F.J., Buja, L.M., Willerson, J.T., Campbell, W.B.: Augmented vasoconstrictor responses to serotonin precede the development of atherosclerosis in the aorta of the WHHL rabbit. Arteriosclerosis 9:195-202, 1989.
7. Pfister, S.L., Rosolowsky, M., Schmitz, J.M., Clubb, F.J., Jr., Campbell, W.B.: Eicosapentaenoic acid alters vascular reactivity and platelet adhesion in Watanabe Heritable Hyperlipidemic rabbits. Eur. J. Pharmacol. 161:85-89, 1989.
8. Rosolowsky, M., Pfister, S.L., Buja, L.M., Clubb, F.J., Campbell, W.B.: Method of removal of aortic endothelium affects arachidonic acid metabolism & vascular reactivity. Eur. J. Pharm. 193:293-300, 1990.
9. Pfister, S.L., Falck, J.R., Campbell, W.B.: Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am. J. Physiol. 261:H843-H852, 1991.
10. Pfister, S.L., Campbell, W.B.: Arachidonic acid- and acetylcholine-induced relaxations of rabbit aorta. Hypertension 20:682-689, 1992.
11. Buzzard, C.J., Pfister, S.L., Campbell, W.B.: Endothelial dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2. Circ. Res. 72:1023-1034, 1993.
12. Buzzard, C.J., Pfister, S.L., Halushka, P.V., Campbell, W.B.: Decrease in vascular thromboxane A2 receptors in a subgroup of rabbits unresponsive to a thromboxane A2 mimetic. Am. J. Physiol. 266:H2320-H2326, 1994.
13. Pfister, S.L., Spitzbarth, N., Edgemond, W., Campbell, W.B. : Vasorelaxation by an endothelium-derived metabolite of arachidonic acid. Am J. Physiol. 270:H1021-1030, 1996.
14. Pfister, S.L and Campbell, W.B.: Role of endothelium-derived metabolites of arachidonic acid in the enhanced pulmonary artery contractions in female rabbits. Hypertension 27:43-48, 1996.
15. Pfister, S.L.,Campbell, W.B.: Reduced pulmonary artery vasoconstriction to methacholine in cholesterol-fed rabbits. Hypertension 27[part 2]:804-810, 1996.
16. Pfister, S. L. ,Campbell, W.B.: Contribution of arachidonic acid metabolites to reduced norepinephrine induced contractions in hypercholesterolemic rabbit aortas. J. Cardio. Pharm. 28:784-791, 1996.
17. Pfister, S.L., Kotulock, D.A., Campbell, W.B.: Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits. Hypertension 29:303-309, 1997.
18. Pfister, S.L., Deinhart, D., Campbell, W. B.: Methacholine-induced contraction of rabbit pulmonary artery: Role of platelet-endothelial transcellular thromboxane synthesis. Hypertension 31:206-212, 1998.
19. Pfister, S.L., Spitzbarth, N. Nithipatikam, K., Edgemond, W, Falck, J.R., Campbell, W.B.: Identification of the 11,14, 15- and 11,12,15-trihydroxyeicosatrienoic acid as an endothelium-derived relaxing factors of rabbit aorta. J. Biol. Chem. 273: 30879-30887, 1998.
20. Fike, C.D., Pfister, S.L., Kaplowitz, M.R., Madden, J.A.: Cycloxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs, J. Appl. Physiol. 92:67-74, 2002.
21. Sherman, T.S., Chambliss, K.L., Gibson, L.L., Pace, M.C., Mendelsohn, M.E., Pfister, S.L., Shaul, P.W.: Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir. Cell Mol. Biol. 26:610-616, 2002.
22. Pfister, S.L., Hughes, M.J., Rosolowsky, M., Campbell, W.B.: Role of contaminating platelets in thromboxane B2 synthesis in primary cultures of human umbilical vein endothelial cells, Prostaglandins other Lipid Med. 70:39-49,2002.
23. Fike, C.D.,Kaplowitz, M.R., Pfister, S.L.: Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs, Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L316-323, 2003.
24. Pfister, S.L., Spitzbarth, N., Nithipatikom, K., Falck, J.R., Campbell, W.B.: Metabolism of 12- hydroperoxyeicosatetraenoic acid to vasodilatory trioxilin C3 by rabbit aorta. Biochim Biophys Acta.1622:6-13., 2003.
25. Campbell, W.B., Spitzbarth, N., Gauthier, K.M., Pfister, S.L.: 11,12,15-Trihydroxyeicosatrienoic acid mediates ACh-induced relaxations in rabbit aorta. Am J Physiol Heart Circ Physiol.285:H2648-56, 2003.
26. Pfister, S.L., Spitzbarth ,N., Zeldin, D.C., Lafite, P., Mansuy, D., Campbell, W.B.: Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450. Arch Biochem Biophys.420:142-52, 2003.
27. Pfister, S.L.: The role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 43:428-433, 2004.
28. Rademacher, D.J., Kearn, C.S., Carrier,E.J., Patel, S., Delgado, M., Barkmeier, A., Klick, D.E., Breese, N.M., Pfister, S.L., Nithipatikom, N., Campbell, W.B., Hillard, C.J.: Production of hydroxyeicosatetraenoic acids (HETEs) and prostaglandins by a novel rat microglial cell line, J Neuroimmunol,149:130-141, 2004.
29. Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister, S.L., Campbell, W.B., Hillard, C.J.: Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor dependent mechanism, Mol Pharmacol, 65:999-1007, 2004
30. Pfister, S.L., Pratt, P, Kurian, J, Campbell, W.B.: Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade. Vascular Pharmacol, 40:285-292, 2004
31. Fike CD, Kaplowitz MR, Zhang Y, Pfister SL.Cyclooxygenase 2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs. J Appl Physiol. 98:1111-1118, 2005.
32. Pfister, SL: Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits Atherosclerosis, 189:358-363, 2006.
33. Pfister, SL: Role of lipoxygenase metabolites of arachidonic acid in enhanced pulmonary artery contractions of female rabbits, Hypertension, 57:825-832, 2011. PMID: 21300669; PMCID: PMC3073701.
34. Pfister SL. Characterization of endothelial thromboxane receptors in rabbit aorta. Prostaglandins Other Lipid Mediat. 87:54-61. 2008
35. Pfister, SL, Nithipatikom, K, Campbell, WB: Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels. Amer J Physiol Heart Circ Physiol, 300(6):H2064-7, 2011 PMID:21460202.
36. Fike, CD, Aschner, JL, Kaplowitz, MR, Zhang, Y, Pfister, SL: Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension,Pediatric Research, 70(2):136-41, 2011. PMID:21516056
37. Pfister, S.L., Somberg, L., Lowry, T., Gao, Y. Medhora, M. and E.R. Jacobs. Mechanisms underlying increased reactivity of pulmonary arteries contralateral to a localized high-flow anastomosis. J Thor Cardio Surg, 141:425-431, 2011. PMID: 21075383 PMCID:PMC3052931.
38. Fike, C.D., Pfister, S.L., Slaughter, J.C., Kaplowitz, M.R., Zhang, Y., Zeng, H., Frye, N.R. and Aschner, J.L. Protein complex formation with heat shock protein 90 (Hsp90) in chronic hypoxia-induced pulmonary hypertension in newborn piglets. Amer J Physiolol,Oct;299(4):H1190-204. Epub 2010 Aug 6.2010 PMID:20693398
39. Siangjong,L, Gauthier,KM Pfister,SL, Smyth, EM and Campbell, WB. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries,Amer J Physiol 304(3):H382-92,2013 PMCID:PMC3774504
40. Ma S, Yin N, Qi X, Pfister SL, Zhang MJ, Ma R, Chen G. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015 May 30;6(15):13320-33. PMCID: PMC4537017
41. Pfister SL, Klimko PG, Conrow RE. (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid: A stable isomer of 15(S)-HETE that retains key vasoconstrictive and antiproliferative activity. Prostaglandins Other Lipid Mediat. 2016 03;123:33-9. PMCID: PMC4893888
42. Pfister, SL, Mechanism of 15-HETE-induced contractions in female and male pulmonary arteries. in preparation, 2017
43. S Park, A Herrnreiter, SL Pfister, KM Gauthier, BA Falck, JR. Falck and WB Campbell. Characterization of GPR40 as a Low Affinity Epoxyeicosatrienoic Acid Receptor in Vascular Cells, Am J Physiol in revision, 2017
44. Park SK, Herrnreiter A, Pfister SL, Gauthier KM, Falck BA, Falck JR, Campbell WB. GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells. J Biol Chem. 2018 07 06;293(27):10675-10691. PMCID: PMC6036206
 
Books, Chapters, and Reviews
1. Pfister, SL, Spitzbarth, N, Nithipatikom, K, Edgemond, WS, Campbell, WB: Endothelium-derived eicosanoids from lipoxygenase relax the rabbit aorta by opening potassium channels. In Endothelium- Dependent Hyperpolarizations, PM Vanhoutte, Ed., Harwood Acad Publishers, Canada, p.17-28, 1999.
2. Pfister, S.L., Spitzbarth, N., Gauthier, K.M.,Campbell, W.B.: Identification of 11,12,15-trihydroxyeicosatrienoic acid as the mediator of acetylcholine- and arachidonic acid-induced relaxations in the rabbit aorta. In Endothelium-Dependent Hyperpolarizations, PM Vanhoutte, Ed., Taylor & Francis, London,p 239-248, 2001.
3. Pfister, S.L., Gautheir, K.M. Campbell, W.B: Vascular pharmacology of epoxyeicosatrienoic acids. In Advances in Pharmacology, PM Vanhoutte, Ed. Vol. 60:27-59, 2010
 
Abstracts
1. Pfister, S.L. and Keeton, T.K.: Rauwolscine-induced renin release in the conscious rat. Fed. Proc. 41:1232, 1982.
2. Pfister, S.L., Biediger, A.M., Lopez, M.D. and Keeton, T.K.: The hemodynamic and endocrine effect of yohimbine and rauwolscine in conscious rats. Fed. Proc. 42:617, 1983.
3. Lopez, M.D., Pfister, S.L., Brennan, T.J. and Haywood, J.R.: The effect of yohimbine on thirst. Fed. Proc. 42:610, 1983.
4. Pfister, S.L. and Keeton, T.K.: A comparison of the hemodynamic and endocrine effects of yohimbine and rauwolscine in the conscious rat. Prog. Neuro-Psychopharmacol. (Suppl):248-249, 1983.
5. Keeton, T.K. and Pfister, S.L.: Potentiation by yohimbine of the endocrine effects caused by hydralazine in the conscious rat. Prog. Neuro-Psychopharmacol. (Suppl):187, 1983.
6. Pfister, S.L., Biediger, A.M., Lopez M.D. and Keeton, T.K.: Effect of renal denervation and adrenalectomy of yohimbine-induced renin release in the conscious rat. Fed. Proc. 43:811, 1984.
7. Keeton, T.K. and Pfister, S.L.: Yohimbine amplifies the neuro-endocrine effects of hydralazine and prazosin in the conscious rat. Fed. Proc. 43:813, 1984.
8. Pfister, S.L., Hubbard, J.W. and Keeton T.K.: Measurements of yohimbine in rat brain and plasma using HPLC. Fed. Proc. 44:1117, 1985.
9. Keeton, T.K., Biediger, A.M. and Pfister, S.L.: A comparison of the hemodynamic and neuroendocrine effects of 2-adrenoreceptor antagonists. Fed. Proc. 44:1571, 1985.
10. Pfister, S.L., Schmitz, J.M., Willerson, J.T. and Campbell, W.B.: Metabolism of arachidonic acid in 1 yr old New Zealand white (NZW) and Watanabe heritable hyperlipidemic (WHHL) rabbit aortas. Fed. Proc. 45:456, 1986.
11. Pfister, S.L., Schmitz, J.M., Willerson, J.T. and Campbell, W.B.: Synthesis of monohydroxyeicosatetraenoic acids (HETEs) in Watanabe Heritable Hyperlipidemic (WHHL) and New Zealand White (NZW) rabbit aortas. Fed. Proc. 46:375, 1987.
12. Pfister, S.L. and Campbell, W.B.: Lipoxygenase and epoxygenase metabolism of arachidonic acid in cholesterol-fed rabbit aorta. Circulation 78:II-338, 1988.
13. Pfister, S.L. and Campbell, W.B.: Comparison of arachidonic acid- and acetylcholine-induced relaxations of rabbit aorta. FASEB J. 4:A310, 1990.
14. Rosolowsky, M., Pfister, S.L., Buja, L.M. and Campbell, W.B.: Method of removal of endothelium affects synthesis of lipoxygenase metabolites in rabbit aorta. FASEB J. 4:A310, 1990.
15. Pfister, S.L., Buzzard, C.J. and Campbell, W.B.: Endothelial dependent contracting factor released by arachidonic acid in rabbit pulmonary artery. The Physiologist 34:253, 1991.
16. Pfister, S.L., Buzzard, C.J. and Campbell, W.B.: Decrease in vascular thromboxane receptors in a subgroup of nonresponding rabbits. Presented at International Conference on Prostaglandins and Related Compounds. 1992.
17. Edgemond, W.S., Pfister, S.L. and Campbell, W.B.: Characterization of an unknown endothelial metabolite from rabbit aorta. Presented at the International Conference on Prostaglandins and Related Compounds. 1992.
18. Pfister, S.L. and Campbell, W.B. : Enhanced endothelium-dependent contractions in pulmonary arteries from female rabbits. 48th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1994.
19. Pfister, S.L. and Campbell, W.B. Reduced pulmonary artery vasoconstriction in cholesterol-fed rabbits. 49th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1995.
20. Pfister, S.L. and Campbell, W.B. Platelet thromboxane A2 mediates arachidonic acid-induced contractions in rabbit pulmonary artery. Experimental Biology, 1996.
21. Pfister, S.L., Kotulock, D.A. and Campbell, W.B.: Vascular thromboxane A2 receptor-deficient rabbits have lower blood pressure and are protected from arachidonic acid-induced sudden death. 50th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1996.
22. Pfister, S.L., Deinhart, D and Campbell, W.B. : The role of platelets in arachidonic acid-and methacholine-induced contractions of rabbit pulmonary arteries. 51st Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1997.
23. Pfister, S.L., Spitzbarth, N., Nithipatikom, K., Edgemond, W.S. and Campbell, W.B. : Identification of endothelium-derived lipoxygenase metabolites of arachidonic acid that relax rabbit aorta. 52nd Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1998.
24. Le, T.H., Thomas, D., Coffman, T.M. and Pfister, S.L.: Vascular unresponsivenness to thromboxane A2 is associated with a polymorphism at the thromboxane receptor gene locus. . 53rd Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 1999.
25. Gauthier, K.M., Pfister, S.L., Spitzbarth, N, Rusch, N.J. and Campbell, W.B.: Role of 11,12,15-trihydroxyeicosatrienoic acid as a new endothelium-derived relaxing factor. 54th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2000.
26. Fike, C.D., Kaplowitz, M.R. and Pfister, S.L.. Prostacyclin production and synthase abundance are decreased in small pulmonary arteries of chronically hypoxic newborn piglets. American Thoracic Society, 2001.
27. Pfister, S.L., Spitzbarth, N., Gauthier, K. and Campbell, W.B.: Identification of 11,12,15-trihydroxyeicosatrienoic acid as the mediator of acetylcholine- and arachidonic acid-induced relaxations in rabbit aorta, Experimental Biology, 2001
28. Pfister, S.L., Kurian, J., Pratt, P., and Campbell, W.B.: Inhibition of thromboxane-mediated vasoconstriction by sulfonylureas, 55th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2001.
29. Pfister, S.L.: Altered vascular responses in cholesterol-fed rabbits lacking vascular thromboxane receptors, XV Scientific Meeting of the Inter-American Society of Hypertension and Council for High Blood Pressure Research, 2003
30. Pfister, S.L. The role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery 57th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2003.
31. Pfister, SL and Campbell, W.B. : Effect of angiotensin II in rabbits lacking vascular thromboxane receptors, 58th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2004.
32. Pfister, SL: Enhanced arachidonic acid(AA)-induced contractions in pulmonary arteries:role of 15-lipoxygenase and estrogen. 60th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2006.
33. Fike, CD, Kaplowitz, MR, Zhang, Y, Pfister, SL: Prostanoid production and pulmonary microvascular responses to hydrogen peroxide (H2O2) are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension. 8th World Congress for Microcirculation, 2007
34. Fike, CD, Ascher, JL, Kaplowitz, MR, Zhang, Y, Pfister, SL: Prostanoid production and vascular responses to hydrogen peroxide (H2O2) are altered in resistance level pulmonary arteries (PRA) of newborn piglets with chronic hypoxia-induced pulmonary hypertension. Society for Pediatric Research, 2009.
35. Pfister, SL, Aggarwal, NT, Campbell WB: Hypoxia and pulmonary artery vascular function:role of gender; 63rd Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2009.
36. Pillay T and Pfister SL: Characterization of lipoxygenases (LOs) mediating gender-specific pulmonary artery (PA) vasoconstriction to arachidonic acid (AA) 64th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, 2010.
37. Pfister, SL and Pillay, T: Sex-based differences in 15-lipoxygenase and airway reactivity FASEB J March 17, 2011 25:806.5
38. Pfister, SL A Novel Mechanism To Explain Enhanced Pulmonary Artery Vasoconstriction In Female Rabbits. Scientific Abstracts. Pulm Circ 2011;1:508; The 2011 Grover Conference - Risk Factors in Pulmonary Hypertension: Gender, Sex Hormones, Obesity, Novel Genetic Influences and Risk Factors Sedalia, Colorado, USA, 7-11 September, 2011
39. Pfister, SL. Potential role of estrogen in 15-hydroxyeicosatetranoic acid production and activity in human pulmonary artery endothelial cells. 2015 APS Conference:Cardiovascular, Renal and Metabolic Diseases: Physiology and Gender, November 2015.
40. T. Kriska, S. Pfister, W.B. Campbell. Macrophage 12-HETE enhances angiotensin-11 vasoconstriction through iso-thromboxane B2 release in murine aortas. FASEB J April 2017 31:827.18
41. S.Park, A. Herrnreiter, S. L. Pfister, J. R. Falck, and W.B. Campbell. Characterization of GPR40 as a Low Affinity Epoxyeicosatrienoic Acid (EET) Receptor in Vascular Cells. FASEB J April 2017 31:827.6
42. S Pfister, J Kerschner, J Franco, B Hueston, C Maurana, J Raymond. How the Kern Institute is Leading US Medical School Change. 43rd Annual Association for Moral Education, St. Louis, MO November 2017.
43. SL Pfister, AM Hines, AL Rabbitt, AJ Wagner, TP Webb. Student and Faculty Perception of Women’s Health and Sex and Gender Medicine Curriculum at the Medical College of Wisconsin (MCW), Sex and Gender Medicine Health Education Summit, Salt Lake City, Utah, April 2018
44. S Pfister, C Malmsten, S Twining, E Suelzer, P Hurlbut. Using Self-Directed Learning (SDL) to Teach Sex and Gender Medicine to Second-Year Medical (M2) Students, Sex and Gender Medicine Health Education Summit, Salt Lake City, Utah, April 2018
 

jenkins-FCD Prod-410 e9586552fe7f53c71f7923aa6e27aeabbd3c2473